<div id="readability-page-1"><p>Squarepoint Ops LLC reduced its stake in shares of  Bruker Corporation (NASDAQ:BRKR - Free Report) by 42.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor  owned 103,501 shares of the medical research company's stock after selling 77,226 shares during the period. Squarepoint Ops LLC owned about 0.07% of Bruker worth $4,264,000 at the end of the most recent quarter.</p><p>Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Nisa Investment Advisors LLC raised its stake in shares of  Bruker by 377.5% in the 2nd quarter. Nisa Investment Advisors LLC now owns 616 shares of the medical research company's stock valued at $25,000 after purchasing an additional 487 shares in the last quarter.  Huntington National Bank lifted its holdings in  Bruker by 750.0% during the 2nd quarter. Huntington National Bank now owns 731 shares of the medical research company's stock worth $30,000 after buying an additional 645 shares during the last quarter.  Spire Wealth Management acquired a new position in shares of  Bruker in the 2nd quarter worth approximately $32,000.  Caitong International Asset Management Co. Ltd increased its holdings in shares of  Bruker by 1,354.5% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 800 shares of the medical research company's stock valued at $33,000 after acquiring an additional 745 shares during the last quarter.  Finally, Parallel Advisors LLC raised its position in shares of  Bruker by 63.0% during the 2nd quarter. Parallel Advisors LLC now owns 898 shares of the medical research company's stock valued at $37,000 after acquiring an additional 347 shares in the last quarter. Institutional investors own  79.52% of the company's stock. </p><h2>Analyst Upgrades and Downgrades</h2><p>BRKR has been the subject of a number of research reports. TD Cowen lifted their price objective on shares of Bruker from $40.00 to $42.00 and gave the stock a &#34;hold&#34; rating in a report on Tuesday, November 4th. JPMorgan Chase &amp; Co. raised their price target on shares of Bruker from $50.00 to $55.00 and gave the stock an &#34;overweight&#34; rating in a research report on Monday. The Goldman Sachs Group initiated coverage on shares of Bruker in a research report on Tuesday, December 9th. They set a &#34;sell&#34; rating and a $40.00 price objective for the company. Redburn Partners  set a $60.00 price objective on shares of Bruker in a research note on Thursday, November 20th. Finally, UBS Group lifted their target price on Bruker from $40.00 to $43.00 and gave the company a &#34;neutral&#34; rating in a research note on Tuesday, November 4th. One equities research analyst  has rated the stock with a Strong Buy rating, eight have issued  a Buy rating, six have given a Hold rating and two have issued  a Sell rating to the company. According to data from MarketBeat, Bruker  has a consensus rating of &#34;Hold&#34; and an average target price of $52.86.</p><p><b>Read Our Latest Stock Analysis on Bruker</b></p><h2>Bruker Trading Up 1.2%</h2><p>Shares of NASDAQ:BRKR opened at $45.67 on Tuesday. Bruker Corporation has a fifty-two week low of $28.53 and a fifty-two week high of $64.64. The company has a quick ratio of 0.91, a current ratio of 1.85 and a debt-to-equity ratio of 0.81. The company has a market cap of $6.94 billion, a PE ratio of -285.44, a P/E/G ratio of 6.64 and a beta of 1.17. The company's 50-day moving average price is $41.86 and its 200 day moving average price is $38.39. </p><p>Bruker (NASDAQ:BRKR - Get Free Report) last announced its quarterly earnings results on Monday, November 3rd. The medical research company reported $0.45 EPS for the quarter, beating the consensus estimate of $0.33 by $0.12. The company had revenue of $860.50 million for the quarter, compared to analyst estimates of $847.40 million. Bruker had a negative net margin of 0.61% and a positive return on equity of 15.45%. Bruker's revenue was down .5% compared to the same quarter last year. During the same quarter last year, the business earned $0.60 earnings per share. Bruker has set its FY 2025 guidance at 1.850-1.90 EPS.  Sell-side analysts anticipate that  Bruker Corporation will post 2.69 earnings per share for the current year. </p><h2>Bruker Dividend Announcement</h2><p>The firm also recently declared a quarterly dividend, which will be paid on Friday, January 2nd. Shareholders of record on Monday, December 8th will be given a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date is Monday, December 8th. Bruker's payout ratio is -125.00%. </p><h2>Insider Activity</h2><p>In other news, Director John A. Ornell sold 6,233 shares of the firm's stock in a transaction on Thursday, November 6th. The stock was sold at an average price of $39.00, for a total transaction of $243,087.00. Following the transaction, the director directly owned 35,212 shares of the company's stock, valued at approximately $1,373,268. This trade represents a 15.04% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is accessible through the SEC website. Insiders own  27.30% of the company's stock. </p><h2>Bruker Company Profile</h2> (Free Report)<p>Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy &amp; Supercon Technologies.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Bruker</li><li>Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index</li><li>ServiceNow’s $7 Billion Gamble: Panic or Opportunity?</li><li>What is a Dividend Harvesting Strategy and How Can Investors Profit from it?</li><li>Dell and HP Are Raising Prices—And Investors Should Take Note</li><li>Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?</li><li>Why DLocal Is the Top Emerging Market Fintech Stock to Watch for 2026</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QlJLUg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QlJLUg"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Bruker Right Now?</h2><p>Before you consider Bruker, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bruker wasn't on the list.</p><p>While Bruker currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

BRKR

<p>Squarepoint Ops LLC reduced its stake in Bruker Corporation by 42.7% in Q2, owning 103,501 shares worth $4.26 million. Other institutional investors adjusted their holdings, with some increasing their stakes. Analysts have mixed ratings on Bruker, with a consensus "Hold" rating and an average target price of $52.86. Bruker's stock opened at $45.67, with a 52-week range of $28.53 to $64.64. The company reported Q3 earnings of $0.45 per share, beating estimates, and announced a quarterly dividend of $0.05 per share.</p>

Bruker Corporation $BRKR Shares Sold by Squarepoint Ops LLC